Bombesin- and CCK-related peptides are found widely in the gastrointestinal (GI) tract and central nervous system, however, aspects of their cellular basis of action remain unclear, particularly the role of tyrosine phosphorylation in their signaling cascade. In our recent studies the cellular basis of action of bombesin receptors and cholecystokinin-A (CCK) receptors [CCK-A-R] are being examined. A new bombesin receptor that has been described in amphibians, bombesin receptor subtype-4 [BB-4-R] and during this last year it has been successfully stably expressed in a mammalian cell, CHO-K-1 which allows its cell biology and pharmacology to be studied for the first time. Our studies demonstrate this receptor is coupled to phospholipase C with activation stimulating both changes in (Ca-2+),-and inositol phosphates, as well as being coupled to phospholipase D [Biochemistry 38:7307, 1999.] In previous studies CCK-A-R activation has been shown to be coupled to activation of phospholipase C with mobilization of cellular [Ca-2+], and activation of PKC, PLD, and PLA-2. Recent studies by us (Adv. Mol. Cell. Endrinol. 3, 119, 1999) and others show increased tyrosine phosphorylation may also be an important cellular cascade. We have demonstrated CCK-A-R causes tyrosine phosphorylation of p125 focal adhesion kinase and paxillin and in a study this year demonstrated it also caused tyrosine phosphorylation of p130-cas (Biochemistry 38:1497, 1999). We found rapid tyrosine phosphorylation of p130-cas (Crk-associated substrate) by CCK through PLC dependent-and independent pathways that was dependent on the small G protein, p21-rho and the integrity of the actin cytoskeleton. Activation of this pathway resulted in the translocation of p130-cas to the plasma membrane and coupling to c-CrK. Because p130-cas is a major intracellular adapter molecule with both numerous SH-3 and SH-2 binding domains, as is CrK, and functions as a molecular switch, its activation suggests it may be an important mediator of CCKs downstream effects, especially growth. - bombesin receptors, CCK receptors, p125-FAK, p130-cas,

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK053101-11
Application #
6289814
Study Section
Special Emphasis Panel (DDB)
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
González, Nieves; Mantey, Samuel A; Pradhan, Tapas K et al. (2009) Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. Peptides 30:1473-86
Gonzalez, Nieves; Nakagawa, Tomoo; Mantey, Samuel A et al. (2009) Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor. J Pharmacol Exp Ther 331:265-76
Jensen, R T; Battey, J F; Spindel, E R et al. (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42
Gonzalez, Nieves; Hocart, Simon J; Portal-Nunez, Sergio et al. (2008) Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor. J Pharmacol Exp Ther 324:463-74
Gonzalez, Nieves; Moody, Terry W; Igarashi, Hisato et al. (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15:58-64
Berna, Marc J; Jensen, Robert T (2007) Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem 7:1211-31
Moody, Terry W; Mantey, Samuel A; Fuselier, Joseph A et al. (2007) Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Peptides 28:1883-90
Berna, Marc J; Tapia, Jose A; Sancho, Veronica et al. (2007) Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential. Curr Opin Pharmacol 7:583-92
Berna, Marc J; Hoffmann, K Martin; Tapia, Jose A et al. (2007) CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim Biophys Acta 1773:483-501
Corleto, V D; Severi, C; Romano, G et al. (2006) Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil 18:217-25

Showing the most recent 10 out of 27 publications